Erasca (ERAS) Capital Expenditures Growth (3y) (2023 - 2026)
Erasca (ERAS) Capital Expenditures Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Erasca |
4.28 Bn |
4.03 Bn |
- |
-68.98% |
| Date | Value |
|---|
| Mar 31, 2026 |
-68.98% |
| Dec 31, 2025 |
-78.16% |
| Sep 30, 2025 |
-85.04% |
| Jun 30, 2025 |
-81.26% |
| Mar 31, 2025 |
-77.55% |
| Sep 30, 2024 |
-89.77% |
| Jun 30, 2024 |
-71.79% |
| Mar 31, 2024 |
-29.91% |
| Dec 31, 2023 |
48.58% |
| Sep 30, 2023 |
17.22% |
